Position in ALVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$89,877
+$8,134 QoQ
Shares Held
24,357
+2.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 72 holders
Holding Since
Jun 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $487,957,812 across 61 Drug Manufacturers - Specialty & Generic names. ALVO ranks #38 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,302,737 | $165,474,680 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
324,807 | $54,742,970 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,343,554 | $45,519,608 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
72,010 | $39,017,177 | |
| 5 | VTRS |
Viatris Inc
|
2,437,004 | $38,699,622 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
907,024 | $37,215,193 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
861,006 | $29,851,076 | |
| 8 | ALKS |
Alkermes plc.
|
219,935 | $11,524,592 |
All Filings in ALVO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $89,877 | 24,357 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $81,743 | 23,832 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $79,304 | 15,459 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $173,660 | 21,204 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $191,738 | 21,024 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $219,189 | 22,667 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $209,827 | 15,860 | Shares | Sole | 2026-03-19 | |
| 2022-06-30 | $10,311 | 1,256 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||